ANDA 200044, held by Accord Hlthcare. Pioglitazone Hydrochloride.
As of Nov 16, 2026, ANDA 200044 (Pioglitazone Hydrochloride), held by Accord Hlthcare, was first approved by FDA on Feb 13, 2013, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 13, 2013 | Original application | Approved | None posted |
| Pioglitazone HydrochlorideEQ 15MG BASE · tablet;oral | Pioglitazone Hydrochloride | Rx |
| Pioglitazone HydrochlorideEQ 30MG BASE · tablet;oral | Pioglitazone Hydrochloride | Rx |
| Pioglitazone HydrochlorideEQ 45MG BASE · tablet;oral | Pioglitazone Hydrochloride | Rx |
| Sep 8, 2020 | Supplement 3Labeling · Standard review | Approved | None posted |
| Sep 8, 2020 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jul 21, 2015 | Supplement 1Labeling · Standard review | Approved | None posted |
| Feb 13, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters